Document Detail


Is cerebral autoregulation impaired in Parkinson's disease? A transcranial Doppler study.
MedLine Citation:
PMID:  17275849     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Orthostatic hypotension (OH) is one of the many autonomic disturbances observed in Parkinson's disease (PD). It has been debated whether an additional impairment of cerebral autoregulation (CA) in PD patients may exacerbate the consequences of OH upon brain perfusion. We assessed CA in PD patients and the potential influence of dopaminergic agents. CA was determined by means of transcranial Doppler (TCD) monitoring of the middle cerebral artery (MCA) at rest and during a thigh cuff release test inducing a systemic blood pressure (BP) drop. Fourteen patients were investigated when taking their usual dopaminergic medication and after drug discontinuation for 12 h. A control group was composed of 11 age-matched subjects (CS). In comparison with PD patients, CS presented a significantly higher increase of the mean cerebral blood flow velocities in the MCA after the BP drop. Mean velocities were increased above the initial values in all CS, whereas a flattened curve was observed in PD patients. No significant differences could be further observed between the PD patients regarding the BP, the cerebrovascular resistance, the heart rate and the pulsatility index. These results provide evidence of an impaired cerebral autoregulation in PD patients which appears independent of dopaminergic treatment.
Authors:
N Vokatch; H Grötzsch; B Mermillod; P R Burkhard; R Sztajzel
Related Documents :
22179599 - Spinal anesthesia for cesarean section in a patient with chronic inflammatory demyelina...
9159719 - Clinical and pharmacological differences in early- versus late-onset parkinson's disease.
126679 - Penumoencephalographic findings in parkinsonism.
10384979 - Female voiding dysfunction and movement disorders.
22127469 - (99m)tc-labeled rituximab for imaging b lymphocyte infiltration in inflammatory autoimm...
16538649 - Does seasonal variation affect hallucinations in pd? a longitudinal study.
21207349 - Anticoagulant-associated intracerebral hemorrhage.
17939039 - Evaluation of metabolic syndrome frequency and carotid artery intima-media thickness as...
2786309 - Influence of pharmacological doses of calcitonin on serum osteocalcin concentration in ...
Publication Detail:
Type:  Journal Article     Date:  2007-02-02
Journal Detail:
Title:  Journal of the neurological sciences     Volume:  254     ISSN:  0022-510X     ISO Abbreviation:  J. Neurol. Sci.     Publication Date:  2007 Mar 
Date Detail:
Created Date:  2007-03-06     Completed Date:  2007-05-29     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0375403     Medline TA:  J Neurol Sci     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  49-53     Citation Subset:  IM    
Affiliation:
Department of Neurology, Geneva University Hospitals and Medical School, Switzerland. Natalia.Vokatch@hcuge.ch
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Autonomic Dysreflexia / etiology,  physiopathology
Blood Flow Velocity
Blood Pressure / drug effects,  physiology
Brain Ischemia / etiology,  physiopathology,  ultrasonography*
Cerebral Arteries / physiopathology,  ultrasonography*
Cerebrovascular Circulation / drug effects,  physiology*
Dopamine Agents / adverse effects,  therapeutic use
Female
Homeostasis / drug effects,  physiology
Humans
Male
Middle Aged
Parkinson Disease / complications,  physiopathology,  ultrasonography*
Predictive Value of Tests
Shy-Drager Syndrome / etiology,  physiopathology,  ultrasonography*
Ultrasonography, Doppler, Transcranial
Chemical
Reg. No./Substance:
0/Dopamine Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  In vivo observation of leukocyte-endothelium interaction in ischemia reperfusion injury with the dor...
Next Document:  Increased amyloid beta protein levels in children and adolescents with Down syndrome.